Article
Early Steroid Withdrawal after Liver Transplantation: The Canadian Tacrolimus versus Microemulsion Cyclosporin A Trial: 1-year Follow-up
Liver Transplantation
(2003)
Abstract
Corticosteroid therapy contributes significant toxicity to liver transplantation. The safety and efficacy of early steroid withdrawal were determined in patients treated with either tacrolimus or microemulsion cyclosporin A (micro-CsA). The primary outcome was the proportion of patients who were steroid-free 1 year posttransplantation. From the seven Canadian adult liver transplant centers, 143 patients were randomly allocated oral treatment with either tacrolimus (n = 71) or micro-CsA (n = 72), together with corticosteroids and azathioprine. Eligibility criteria for steroid withdrawal included freedom from acute rejection for a minimum of 3 months, and prednisone
Keywords
- Adrenal Cortex Hormones,
- Canada,
- Cyclosporine,
- Emulsions,
- Graft Rejection,
- Graft Survival,
- Immunosuppressive Agents,
- Liver Transplantation,
- Tacrolimus
Disciplines
Publication Date
June, 2003
Publisher Statement
Dr. Vivian McAlister is currently a faculty member at The University of Western Ontario.
Citation Information
Paul Greig, Leslie Lilly, Charles Scudamore, Siegfried Erb, et al.. "Early Steroid Withdrawal after Liver Transplantation: The Canadian Tacrolimus versus Microemulsion Cyclosporin A Trial: 1-year Follow-up" Liver Transplantation Vol. 9 Iss. 6 (2003) Available at: http://works.bepress.com/vivianmcalister/79/